Bibliographic Details
Title: |
478 COM701 in combination with BMS-986207 (anti-TIGIT antibody) and nivolumab – preliminary results of safety, tolerability and pharmacokinetics in patients with advanced solid tumors (NCT04570839) |
Authors: |
Inbal Barbiro, Amita Patnaik, Manish Sharma, Drew Rasco, Ryan Sullivan, Ecaterina Dumbrava, Pierre Ferre, Gini Fleming, Kyriakos Papadopoulos, Daniel Vaena, Adam ElNaggar, Adeboye Adewoye, Robina Smith, Emerson Lim |
Source: |
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021) |
Publisher Information: |
BMJ Publishing Group, 2021. |
Publication Year: |
2021 |
Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Subject Terms: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
Document Type: |
article |
File Description: |
electronic resource |
Language: |
English |
ISSN: |
2051-1426 |
Relation: |
https://doaj.org/toc/2051-1426 |
DOI: |
10.1136/jitc-2021-SITC2021.478 |
Access URL: |
https://doaj.org/article/79090e9b14894f908bab8530154d36f2 |
Accession Number: |
edsdoj.79090e9b14894f908bab8530154d36f2 |
Database: |
Directory of Open Access Journals |